{"name":"Cerecin","slug":"cerecin","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"oncology","drugs":[{"name":"Axona","genericName":"Axona","slug":"axona","indication":"Other","status":"phase_1"},{"name":"AC-1202 mixed in Ensure®","genericName":"AC-1202 mixed in Ensure®","slug":"ac-1202-mixed-in-ensure","indication":"Other","status":"phase_1"},{"name":"AC-1202 mixed in water","genericName":"AC-1202 mixed in water","slug":"ac-1202-mixed-in-water","indication":"Other","status":"phase_1"},{"name":"AC-1204","genericName":"AC-1204","slug":"ac-1204","indication":"Other","status":"phase_2"},{"name":"AC-1204 mixed in water","genericName":"AC-1204 mixed in water","slug":"ac-1204-mixed-in-water","indication":"Other","status":"phase_1"},{"name":"AC-OLE-01-VA","genericName":"AC-OLE-01-VA","slug":"ac-ole-01-va","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Axona","genericName":"Axona","slug":"axona","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AC-1202 mixed in Ensure®","genericName":"AC-1202 mixed in Ensure®","slug":"ac-1202-mixed-in-ensure","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AC-1202 mixed in water","genericName":"AC-1202 mixed in water","slug":"ac-1202-mixed-in-water","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AC-1204","genericName":"AC-1204","slug":"ac-1204","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AC-1204 mixed in water","genericName":"AC-1204 mixed in water","slug":"ac-1204-mixed-in-water","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AC-OLE-01-VA","genericName":"AC-OLE-01-VA","slug":"ac-ole-01-va","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxNelhGRWdNOUpyWkFNSHZzMml5MHFvYnpHMmVhN0RjRmZ6UW5WR0hMeTM2SG91enFaNUk0ODRmekxuQWxjMHo1eHRpRlR4ZXZLNFpIOEkzQTRMMnNDaWNiUXQtMFFON2VFSWRJUUp4MXUySklNUThyRXlVSlYyOEVyR1hENnBUT1gtQmtGTDE1clFDNmhYWWNGTG1VSVFWUXl1cnBSNW9Rdkdpa0FFU3RsWlZXVVVJc2VoOFZRZ1lPekVyTUtLZGNGM0cxMlZaQkstMFRzbkx5YVNHdzJmbm1qOEdKWFhQQ3dDNWFCZXJYS2JOUjhCM0Z2OVV0Z3NocUpVRTJSY3BKSzVoaVowOWpkZzROSXV3dkFVRm9EVVlxNmNPVmM?oc=5","date":"2025-04-08","type":"pipeline","source":"GlobeNewswire","summary":"Developmental and Epileptic Encephalopathies Market to - GlobeNewswire","headline":"Developmental and Epileptic Encephalopathies Market to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE9sMTZrMnNUTzFtOHhpaE5RY1ZCWE53MGd6MXNiT29uOUN3cU1VRlI0NkxFZkNQd2RrVlIzSk53UzRDVk5HekxmbWtNb29uWkFaRDhvRlUtNA?oc=5","date":"2024-09-25","type":"pipeline","source":"매일경제","summary":"Cerecin on track to develop oral dementia drug - 매일경제","headline":"Cerecin on track to develop oral dementia drug - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQM3BvSHlNTnQ4RHM4OUNJNS1NTjNabjliLUhxVVRJRTVRR19HV3E1MFNpdk9Ob3BzSUpFV0U3X1ZiX3RlSENucG0xMlZKS29DLVhGT2E0NWdWQ1AtUVpIOFl0YTdoWnBCUnppeV81NVktaTllMkh1Z0VtVHVON3FhblZPc0Ryd3JTVEdzTEI2Qi0yaWZXb1c4X2VQNV9OdUZtdGx1NXFjRVpESDRBakREN3hvaUlnbUlKY3VhX3Y1Zk9kenBmYk52YTd2c01XbE11RURfVDNB?oc=5","date":"2023-07-03","type":"trial","source":"BioPharma APAC","summary":"Promising Clinical Trial Data for Migraine Treatment: CER-0001, a Ketogenic Investigational Agent - BioPharma APAC","headline":"Promising Clinical Trial Data for Migraine Treatment: CER-0001, a Ketogenic Investigational Agent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQT3RyYktjSkFpUHpNU2wxRl9HUTZfUmp3V1otWW04WEZYOURpU2lya3luZzVGMFVhZU5seWRTZWpBZzd1dnBXUmJLYmZyeFZVd2dzYnNUeVA5SnZFX200bGMxM0RSdno3ZVpoS21XdUtWUWluVVN0R3g1cXdNQWRwdWlBU2Y0S3BCS1M0YXZ3OVZwWkFJYmtlX2N0MjM4TTNzS3ZfSDVHNlhJYlkwRUQ2b205dVhqSEZfeWNKVTRqckhzcTZ5UWhxcDNsUlA4UFJxZGRycUhpTk1XZw?oc=5","date":"2019-11-04","type":"pipeline","source":"BioSpace","summary":"Cerecin strengthens its leadership position in CNS drug development by adding a biotech veteran to the executive team - BioSpace","headline":"Cerecin strengthens its leadership position in CNS drug development by adding a biotech veteran to the executive team","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_1":5,"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}